Literature DB >> 31996960

Sedation practice and discomfort during withdrawal of mechanical ventilation in critically ill patients at end-of-life: a post-hoc analysis of a multicenter study.

Rene Robert1,2,3, Amélie Le Gouge4,5, Nancy Kentish-Barnes6, Mélanie Adda7, Juliette Audibert8, François Barbier9, Simon Bourcier10,11, Jeremy Bourenne12, Alexandre Boyer13,14, Jérôme Devaquet15, Guillaume Grillet16, Olivier Guisset13,17, Anne-Claire Hyacinthe18, Mercé Jourdain19,20, Nicolas Lerolle21,22, Olivier Lesieur23, Emmanuelle Mercier24,25,26, Jonathan Messika27, Anne Renault28,29, Isabelle Vinatier30, Elie Azoulay31, Arnaud W Thille32,33,31, Jean Reignier34,35.   

Abstract

PURPOSE: Little is known on the incidence of discomfort during the end-of-life of intensive care unit (ICU) patients and the impact of sedation on such discomfort. The aim of this study was to assess the incidence of discomfort events according to levels of sedation.
METHODS: Post-hoc analysis of an observational prospective multicenter study comparing immediate extubation vs. terminal weaning for end-of-life in ICU patients. Discomforts including gasps, significant bronchial obstruction or high behavioural pain scale score, were prospectively assessed by nurses from mechanical ventilation withdrawal until death. Level of sedation was assessed using the Richmond Agitation-Sedation Scale (RASS) and deep sedation was considered for a RASS - 5. Psychological disorders in family members were assessed up until 12 months after the death.
RESULTS: Among the 450 patients included in the original study, 226 (50%) experienced discomfort after mechanical ventilation withdrawal. Patients with discomfort received lower doses of midazolam and equivalent morphine, and were less likely to have deep sedation than patients without discomfort (59% vs. 79%, p < 0.001). After multivariate logistic regression, extubation (as compared terminal weaning) was the only factor associated with discomfort, whereas deep sedation and administration of vasoactive drugs were two factors independently associated with no discomfort. Long-term evaluation of psychological disorders in family members of dead patients did not differ between those with discomfort and the others.
CONCLUSION: Discomfort was frequent during end-of-life of ICU patients and was mainly associated with extubation and less profound sedation.

Entities:  

Keywords:  Discomfort; End-of-life; Sedation; Withdrawal mechanical ventilation

Mesh:

Substances:

Year:  2020        PMID: 31996960     DOI: 10.1007/s00134-020-05930-w

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  5 in total

1.  Dying in the ICU : Changes in end of life decisions from 2011 to 2018 in the ICU of a communal tertiary hospital in Germany.

Authors:  Isabel Schulmeyer; Markus A Weigand; Monika Heinzel-Gutenbrunner; Marco Gruss
Journal:  Anaesthesiologie       Date:  2022-05-23

2.  Admission decisions to intensive care units in the context of the major COVID-19 outbreak: local guidance from the COVID-19 Paris-region area.

Authors:  Élie Azoulay; Sadek Beloucif; Bertrand Guidet; Dominique Pateron; Benoît Vivien; Matthieu Le Dorze
Journal:  Crit Care       Date:  2020-06-05       Impact factor: 9.097

3.  End of life in the critically ill patient: evaluation of experience of end of life by caregivers (EOLE study).

Authors: 
Journal:  Ann Intensive Care       Date:  2021-11-26       Impact factor: 6.925

4.  End-of-Life and Palliative Care in a Critical Care Setting: The Crucial Role of the Critical Care Pharmacist.

Authors:  Rhona Sloss; Reena Mehta; Victoria Metaxa
Journal:  Pharmacy (Basel)       Date:  2022-08-31

Review 5.  Pain management during the withholding and withdrawal of life support in critically ill patients at the end-of-life: a systematic review and meta-analysis.

Authors:  Andres Laserna; Alejandro Durán-Crane; María A López-Olivo; John A Cuenca; Cosmo Fowler; Diana Paola Díaz; Yenny R Cardenas; Catherine Urso; Keara O'Connell; Clara Fowler; Kristen J Price; Charles L Sprung; Joseph L Nates
Journal:  Intensive Care Med       Date:  2020-08-24       Impact factor: 17.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.